Cheong Fei Wen obtained her Bachelor Degree in Biomedical Science (with distinction) from Universiti Malaya (UM), Malaysia. She passed her PhD with distinction and is currently holding the post of senior lecturer in the Department of Parasitology, Faculty of Medicine, UM. Since PhD study, she explored into several malaria-related aspects, including protein expression of the Plasmodium knowlesi merozoite surface proteins; immunogenicity study using animal model; and epitope mapping. Her current research interests include phenotypic and genotypic measures on Plasmodium sp. resistance against anti-malarials, immunogenicity profiling of potential malarial vaccine candidates, and genome engineering in P. knowlesi using CRISPR-Cas9 system. With her deep passion in research, she has been successfully selected and awarded to attend several international workshops/courses including Ungku Omar-Newton Fund Researcher Links Workshop: Neglected Disease in SEA: Building Capacity in Epidemiological Modelling (University of Malaya, Malaysia & Imperial College London, UK) and Wellcome Genome Campus Advanced Course: Malaria Experimental Genetics (WGCAC, UK). She has also obtained and be part of 10 research grants, including UM Research Fund Assistance (BKP), UM Research Excellence Grant (UMREG), Postgraduate Research Fund (PPP), Frontier Research Grant (FRG), Fundamental Research Grant Scheme (FRGS), and Long Term Research Grant Scheme (LRGS), with total amount exceeding RM 2 million. With that, she has published more than 30 articles in ISI-indexed journals.  She is currently the assistant editor of the Journal of Health and Translational Medicine (JUMMEC), associate editor of Asia Pacific Journal of Molecular Biology and Biotechnology (APJMBB), and editorial board member of Tropical Biomedicine. She was the council member for Malaysian Society of Parasitology and Tropical Medicine (MSPTM) in 2019-2020.  She received excellent service certificate and excellent service award, UM in 2019 and 2024, respectively. She has been appointed as Programme Coordinator and assisted the department to develop a new Master by Coursework programme (Master of Medical Parasitology and Entomology, MMPE). She is also the course coordinator for courses in MMPE and Biomedical Science Programme. She is the committee member of Quality Assurance Programme - Quality Committee, Faculty of Medicine (FOM) from 2020. With her interest in academic curriculum, she has also been appointed as Programme Quality Assurance Expert (Pro-QAE) of FOM in 2021, and Pro-QAE of UM in 2024 to assist in programme curriculum related matters. In 2025, she has been appointed as FOM Deputy Quality Manager (ProQAE and stakeholders' feedback). 

Rozie Sarip, originally from Shah Alam, Selangor, completed her BSc in 2004 and MSc in 2007 at Universiti Teknologi Malaysia (UTM). She earned her PhD in Inorganic Chemistry in 2012 from University College London, working with Dr. Graeme Hogarth FRSC and Prof. Gopinathan Sankar FRSC. Rozie began her career at SIRIM Bhd. as an Associate Researcher in August 2006 before becoming a Research Officer at the Institute for Medical Research (IMR) in Kuala Lumpur. After completing her PhD, she returned to IMR for another year and then joined the University of Malaya (UM) as a lecturer on March 10, 2014. She is a member of both the Royal Society of Chemistry and the Institut Kimia Malaysia. Her research focuses on: - Binuclear and cluster chemistry - Homogeneous and heterogeneous catalysis - Synthesis of phosphines and diphosphines stabilized clusters - Synthesis of thiazoline derivatives Rozie's group studies the chemistry of transition metals, emphasizing the synthesis of new transition metal complexes using NMR spectroscopy and X-ray crystallography. Their research includes designing new ligands and developing nanomaterials, with applications in catalysis and bio-inorganic fields, such as drug delivery systems and anti-cancer treatments. They collaborate widely with various local and international partners. Clusters, which contain three or more metal ions, are central to her research, particularly low-valent compounds that exhibit unique properties when combining different metal ions. Their work aims to leverage these compounds as precursors for metal nanoparticles, with a recent achievement in synthesizing small gold nanoparticles from gold-phosphine clusters. They also study the interface between large clusters and small nanoparticles to gain insights into their properties.

Firdaus Aziz is a Senior Lecturer and the Deputy Dean of Research and Innovation at the Faculty of Law, Universiti Malaya. His work centres on medical law, biosafety law, and the legal–ethical dimensions of emerging technologies, including stem cell science, biobanking, gene editing, and precision medicine. He holds a BSc (Hons) in Genetics and Molecular Biology from Universiti Malaya and received the National Science Fellowship to pursue an MA in Biotechnological Law and Ethics at the University of Sheffield. He later completed a DPhil in Public Health at St Edmund Hall, University of Oxford, specialising in stem cell law and ethics at the Centre for Health, Law and Emerging Technologies (HeLEX). Since 2016, he has contributed to strengthening bioethics capacity in Southeast Asia. As a UNESCO Bioethics Trainer, he has delivered training to academicians teaching bioethics in universities across Indonesia, the Philippines, Fiji, and other parts of the region. He is also a co-investigator for the Wellcome Trust–funded Southeast Asian Bioethics Network and for the NIH Fogarty programme developing Malaysia’s Master’s in Health Research Ethics. Firdaus plays an active role in national and regional governance, serving on Malaysia’s Technical Advisory Committee on Dual-Use Research, the National Sub-Committee for Laboratory Biosafety and Biosecurity, and the National Committee on Ethics of Cell Research and Therapy. He provides expert input to government agencies, including the Ministry of Health and the Ministry of Science, Technology and Innovation, contributing to national policy development such as the Guidelines on Stem Cell and Cell-based Research and Therapy (2024) and Malaysia’s first national biotechnology ethics guidelines (2025). He is also involved in national efforts to reform the criminal justice system, with research and supervisory work that engages issues at the intersection of law, public health, and justice sector governance.